Correlation Between Benchmark Botanics and Canntab Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Benchmark Botanics and Canntab Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Benchmark Botanics and Canntab Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Benchmark Botanics and Canntab Therapeutics Limited, you can compare the effects of market volatilities on Benchmark Botanics and Canntab Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Benchmark Botanics with a short position of Canntab Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Benchmark Botanics and Canntab Therapeutics.

Diversification Opportunities for Benchmark Botanics and Canntab Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Benchmark and Canntab is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Benchmark Botanics and Canntab Therapeutics Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Canntab Therapeutics and Benchmark Botanics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Benchmark Botanics are associated (or correlated) with Canntab Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Canntab Therapeutics has no effect on the direction of Benchmark Botanics i.e., Benchmark Botanics and Canntab Therapeutics go up and down completely randomly.

Pair Corralation between Benchmark Botanics and Canntab Therapeutics

Assuming the 90 days horizon Benchmark Botanics is expected to generate 1.34 times less return on investment than Canntab Therapeutics. But when comparing it to its historical volatility, Benchmark Botanics is 1.05 times less risky than Canntab Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Canntab Therapeutics Limited is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  1.03  in Canntab Therapeutics Limited on August 26, 2024 and sell it today you would lose (1.02) from holding Canntab Therapeutics Limited or give up 99.03% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Benchmark Botanics  vs.  Canntab Therapeutics Limited

 Performance 
       Timeline  
Benchmark Botanics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Benchmark Botanics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable forward-looking signals, Benchmark Botanics is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.
Canntab Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Canntab Therapeutics Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's fundamental drivers remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Benchmark Botanics and Canntab Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Benchmark Botanics and Canntab Therapeutics

The main advantage of trading using opposite Benchmark Botanics and Canntab Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Benchmark Botanics position performs unexpectedly, Canntab Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Canntab Therapeutics will offset losses from the drop in Canntab Therapeutics' long position.
The idea behind Benchmark Botanics and Canntab Therapeutics Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes